Nicholas A. Coupe
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Immune Checkpoint Inhibitor Therapy Induced Hypophysitis; A Tertiary Care Centre Experience; Highlighting Detection, Treatment Outcomes and Long Term Endocrinopathies and Recovery.
Journal: Clinical endocrinology
Published: December 12, 2025
Outcomes Following Radiotherapy for Oligoprogressive NSCLC on Immune Checkpoint Inhibitors: A Real-World, Multinational Experience.
Journal: Cancers
Published: November 28, 2025
Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity: A Real-World UK Multi-Centre Study.
Journal: Cancers
Published: July 16, 2025
Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination.
Journal: Journal for immunotherapy of cancer
Published: March 31, 2024
Correction: sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 15, 2023
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 05, 2022
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma.
Journal: Nature medicine
Published: April 06, 2022
Phenotyping of cutaneous toxicities in patients with metastatic malignant melanoma treated with immune checkpoint blockade therapy at a UK tertiary care centre.
Journal: Clinical and experimental dermatology
Published: September 29, 2021
Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles.
Journal: British journal of cancer
Published: December 14, 2020
Interferon-Gamma-Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-Colitis.
Journal: Gastroenterology
Published: November 26, 2020
Last Updated: 09/26/2026